Cardiac Resynchronization Therapy Helps Cancer Survivors With Heart Failure

Cardiac resynchronization therapy (CRT) improved left ventricular ejection fraction (LVEF) after six months in cancer survivors with chemotherapy-induced cardiomyopathy, according to a study published in JAMA. The uncontrolled, prospective, cohort Multicenter Automatic Defibrillator Implantation Trial–Chemotherapy-Induced Cardiomyopathy study was conducted between November 21, 2014, and June 21, 2018, at 12 U.S. tertiary centers with cardio-oncology programs. A … Continue reading Cardiac Resynchronization Therapy Helps Cancer Survivors With Heart Failure